# Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes

> **NCT00511602** · PHASE2 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 123 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Technosphere Insulin
- **DRUG:** Technosphere Placebo

## Key facts

- **NCT ID:** NCT00511602
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2004-11
- **Final completion:** 2005-12
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511602, "Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00511602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*